Best of BS Opinion: What's behind the bull run, can India be financial hub
Here's a selection of Business Standard opinion pieces for the day
)
premium
Illustration: Ajay Mohanty
On Saturday, the Indian Council of Medical Research set a deadline of August 15 for the Covid-19 vaccine that is being developed jointly with Bharat Biotech. Given that human trials, which potentially take months, have not begun, this is a remarkable demand, which the medical fraternity openly suggests has been written under government pressure. As the top edit points out here, the search for a vaccine should not compromise on trials because the costs of an error can be cataclysmic. On Sunday, GSTN, the IT infrastructure provider for the Goods and Service Tax, put out a rare statement pointing to a surge in e-way bills over May and June as a sign that the economy is in rebound mode. To interpret the transition from no activity to limited activity in such an upbeat manner suggests a concerted official effort to generate optimism where little exists. As opinion writers suggest, we’re some distance from a return to sustainable growth. Kanika Datta sums up the views.
Topics : BS Opinion